Abstract
We recruited adolescents to study oral contraceptives versus placebo for dysmenorrhea. We anticipated high discontinuation and concerns about safety, side effects, and sexual behavior. Treatment discontinuation (11%) and loss to follow-up (1%) were lower than expected. The most common reason for nonenrollment was logistical issues (63%). Most participants remained abstinent.
Original language | English (US) |
---|---|
Pages (from-to) | 607-609 |
Number of pages | 3 |
Journal | Journal of Adolescent Health |
Volume | 39 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2006 |
Externally published | Yes |
Keywords
- Adolescents
- Dysmenorrhea
- Oral contraception
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Public Health, Environmental and Occupational Health
- Psychiatry and Mental health